Correlation Engine 2.0
Clear Search sequence regions
Bookmark Forward

QuickView for Ceftizoxime (compound)


PubChem
Name: Ceftizoxime
PubChem Compound ID: 2655
Description: A semisynthetic cephalosporin antibiotic which can be administered intravenously or by suppository. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms. It has few side effects and is reported to be safe and effective in aged patients and in patients with hematologic disorders.
Molecular formula: C13H13N5O5S2
Molecular weight: 383.405 g/mol
DrugBank
Identification
Name: Ceftizoxime
Name (isomeric): DB01332
Drug Type: small molecule
Description: A semisynthetic cephalosporin antibiotic which can be administered intravenously or by suppository. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms. It has few side effects and is reported to be safe and effective in aged patients and in patients with hematologic disorders.
Synonyms:
Ceftizoximum [inn-latin]; Ceftizoxima [inn-spanish]
Brand: Cefizox in plastic container, Eposerin, Cefizox, Epocelin, Ceftix
Category: Cephalosporins, Anti-Bacterial Agents
CAS number: 68401-81-0
Pharmacology
Indication: For the treatment of infections due to susceptible strains of microorganisms.
Pharmacology: Ceftizoxime is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms. It has few side effects and is reported to be safe and effective in aged patients and in patients with hematologic disorders.
Mechanism of Action:
Ceftizoxime is an aminothiazolyl cephalosporin with an extended spectrum of activity against many gram-negative, nosocomially acquired pathogens. It has excellent beta-lactamase stability, with good in vitro activity against Haemophilus influenzae, Neisseria gonorrhoeae and Klebsiella pneumoniae. Ceftizoxime, like the penicillins, is a beta-lactam ...
show more »
Protein binding: 30% protein bound
Biotransformation: Ceftizoxime is not metabolized, and is excreted virtually unchanged by the kidneys in 24 hours.
Route of elimination: Ceftizoxime is not metabolized, and is excreted virtually unchanged by the kidneys in 24 hours.
Affected organisms: Enteric bacteria and other eubacteria
Interactions
Drug interaction:
TobramycinIncreased risk of nephrotoxicity
ProbenecidProbenecid may increase the serum level of ceftizoxime.
AmikacinIncreased risk of nephrotoxicity
NetilmicinIncreased risk of nephrotoxicity
GentamicinIncreased risk of nephrotoxicity

Targets


Transporters